1. Triage performance of PAX1 m /JAM3 m in opportunistic cervical cancer screening of non‒16/18 human papillomavirus-positive women: a multicenter prospective study in China.
- Author
-
Chen X, Jin X, Kong L, Liou Y, Liu P, Dong Z, Zhou S, Qi B, Fei J, Chen X, Xiong G, Hu Y, Liu S, Zhou J, Shou H, and Li L
- Subjects
- Female, Humans, China, DNA Methylation genetics, Prospective Studies, Sensitivity and Specificity, Early Detection of Cancer methods, Early Detection of Cancer statistics & numerical data, Human Papillomavirus Viruses isolation & purification, Paired Box Transcription Factors genetics, Papillomavirus Infections diagnosis, Triage methods, Uterine Cervical Dysplasia diagnosis, Uterine Cervical Dysplasia virology, Uterine Cervical Neoplasms diagnosis, Uterine Cervical Neoplasms virology
- Abstract
Objectives: In this study, we aimed to validate the performance of the PAX1 and JAM3 methylation (PAX1
m /JAM3m ) test as a triage tool for detecting cervical intraepithelial neoplasia grade 3 or worse (CIN3 +) in non-16/18 high-risk human papillomavirus-positive patients (non-16/18 hrHPV +)., Methods: The triage performance of liquid-based cytology (LBC) and the PAX1m /JAM3m test for detecting CIN3 + were compared., Results: In total, 1851 participants had cervical histological outcomes and were included in the analysis. The sensitivity/specificity of the LBC test results with atypical squamous cells of undetermined significance or worse (LBC ≥ ASCUS) and the PAX1m /JAM3m test were 90.1%/26.7% and 84.8%/88.5%, respectively. PAX1m /JAM3m ( +) had the highest diagnostic AUC (0.866, 95% confidence interval (CI) 0.837-0.896) in the whole cohort. All cancers (n = 20) were detected by PAX1m /JAM3m (+). Compared with LBC ≥ ASCUS, PAX1m /JAM3m (+) reduced the number of patients who needed referral for colposcopy by 57.21% (74.66% vs. 17.45%). The odds ratios for detecting CIN3 + by LBC ≥ ASCUS and PAX1m /JAM3m (+) were 3.3 (95% CI 2.0-5.9) and 42.6 (27.1-69.6), respectively (p < 0.001). The combination of LBC ≥ ASCUS or PAX1m /JAM3m (+) slightly increased the diagnostic sensitivity (98.0%, 95% CI: 95.8-100%) and referral rate (77.09%) but reduced the diagnostic specificity (24.8%, 22.7-26.8%)., Conclusions: In non-16/18 hrHPV(+) women, PAX1m /JAM3m was superior to cytology for detecting CIN3 + . Compared with LBC ≥ ASCUS, PAX1m /JAM3m (+) reduced the number of significant referrals to colposcopy without compromising diagnostic sensitivity., (© 2024. The Author(s).)- Published
- 2024
- Full Text
- View/download PDF